Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease

Circulation

Volumn 102, Issue 11, 2000, Pages 1227-1232

  Anderson, Jeffrey L ^a   Muhlestein, Joseph B ^a   Horne, Benjamin D ^a   Carlquist, John F ^a   Bair, Tami L ^a   Madsen, Troy E ^a   Pearson, Robert R ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Amino acids; Coronary disease; Genes; Inflammation; Risk factors

Indexed keywords

C REACTIVE PROTEIN; HOMOCYSTEINE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR;

EID: 0034641652     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.102.11.1227     Document Type: Article

References (30)

1. Prevention conference V: Beyond secondary prevention: Identifying the high-risk patient for primary prevention
2. Homocyst(e)ine and cardiovascular disease: A critical review of the epidemiologic evidence
3. Serum total homocysteine and coronary heart disease
4. Homocysteine in health and disease
5. The metabolism of homocysteine: Pathways and regulation
6. Biochemistry and molecular genetics of cystathionine beta-synthase deficiency
7. The natural history of homocystinuria due to cystathionine beta-synthase deficiency
8. Molecular genetic analysis in mild hyperhomocysteinemia: A common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease
9. A mutation in the methylene-tetrahydrofolate reductase gene is not associated with increased risk for coronary artery disease or myocardial infarction
10. A common mutation in methylenetetrahydrofolate reductase gene is not a major risk of coronary artery disease or myocardial infarction
11. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population
12. Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia
13. Folate intake and food sources in the US population
14. Plasma homocysteine levels and mortality in patients with coronary artery disease
15. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
16. Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction
17. Implementation of a computerized cardiovascular information system in a private hospital setting
18. Genetic distances between the Utah Mormons and related populations
19. Evaluation d'une methode rapide d'immunodosage de la proteine C reactive par polarisation de fluorescence
20. Radioimmunoassay of human C-reactive protein formation
21. Solid phase radioimmunoassay for CRP
22. Enzymatic determination of total serum cholesterol
23. Multilayer film elements for clinical analysis: Applications to representative chemical determinations
24. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intakes
25. Hyperhomocysteinemia after an oral methionine load acutely impairs endothelial function in healthy adults
26. Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins
27. A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians
28. Vitamin supplementation reduces blood homocysteine levels: A controlled trial in patients with venous thrombosis and healthy volunteers
29. Lowering blood homocysteine with folic acid based supplements: Meta-analysis of randomised trials
30. Can dietary supplements with folic acid or vitamin B6 reduce cardiovascular risk?: Design of clinical trials to test the homocysteine hypothesis of vascular disease